A randomized open-label phase II study of Everolimus alone or in combination with Pasireotide LAR in advanced, progressive pancreatic neuroendocrine tumors (pNET): COOPERATE-2 trial
Kulke, M Ruszniewski, P van Cutsem, E Valle, Juan W de Herder, W Pavel, M Degtyarev, E Lam, D Salazar, R Borbath, I
Kulke, M
Ruszniewski, P
van Cutsem, E
Valle, Juan W
de Herder, W
Pavel, M
Degtyarev, E
Lam, D
Salazar, R
Borbath, I
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
A randomized open-label phase II study of Everolimus alone or in combination with Pasireotide LAR in advanced, progressive pancreatic neuroendocrine tumors (pNET): COOPERATE-2 trial. 2015, 102 (42036):131-131 Neuroendocrin